承品质之势，打造新一代磁珠平台——ACRO磁珠矩阵重磅亮相！

核心磁珠原材料与关键技术自主开发，保障质量稳定与供应安全。

产品已完成DMF备案，助力客户加速国际临床与注册进程。

满足细胞制备与工艺开发的多样化需求，适配多场景应用。

提供纳米、微米等丰富的粒径规格选择，高工艺灵活性。

按需偶联靶点与性能调控或GMP级别升级，助力从研发与临床全周期需求。

与GMP级细胞因子、培养基、质控试剂产品协同，提升整体工艺效率与一致性。

Cellectra CD14 分选磁珠（Cat. No. MBS-S001），专为CD14⁺细胞的分离纯化而设计。产品通过在磁珠表面偶联高亲和力的抗CD14单克隆抗体，可实现对单核细胞与巨噬细胞的高效识别与靶向捕获。

The CD14+ cells were isolated from human PBMCs using Cellectra Human CD14 nBeads, premium grade (for cells）(ACROBiosystems, Cat. No. MBS-S001). The isolated cells and non-isolated cells were respectively stained using PE anti-human CD14 antibody, and then analyzed by FCS Express 7 software.

The sorting effect of PBMCs from different donors was slightly different, but all of them could guarantee good purity and cell recovery.

The Cellectra Human CD14 nBeads, premium grade (for cells）(ACROBiosystems, Cat. No. MBS-S001) after acceleration 0-21 days at 37℃or freeze & thaw three times still have good isolation efficiency.

Activation of the purified human T Cells. The purified human T cells were activated using Human T cell Activation/Expansion CD3/CD28 Beads, (ACRO, Cat. No. GMP-MBS001) and Competitor-Beads respectively for 24 hours with CTS Optimizer Medium. Cells were fluorescently stained using PE labeled anti-human CD25 antibody and labeled FITC anti-human CD69 antibody and analyzed by flow cytometry.

点击查看更多数据

ActiveMax® Human CD19 μBeads, premium grade (for cells) (Cat. No. MBS-C002) can activate CD19-specific CAR-T cells by detecting the secretion of IFN- γ in vitro (Routinely tested).

点击查看更多数据

依托丰富的产品矩阵，ACROBiosystems为细胞与基因治疗（CGT）提供从细胞培养、激活、扩增、质控及终产品制备的全流程支持。产品涵盖GMP级细胞因子、无血清培养基、抗体、酶、蛋白偶联磁珠、基质蛋白、质控试剂盒等关键产品，打造系统化、标准化的CGT一体化解决方案，满足从早期开发到临床及商业化阶段的全周期需求。

>>>点击查看更多

GMP智能工厂，铸就国际品质标杆：百普赛斯GMP工厂总投资3.5亿元，占地33亩，建筑总面积超过50,000㎡。采用智能化和模块化的设计，灵活韧性，能适应细胞治疗新技术的不断演进。质量体系遵循NMPA, FDA, EMA等多国GMP法规，符合海内外申报要求。点击查看更多